Adocia Investor Relations Material
Latest events
Q1 2025 TU
14 May, 2025
Investor Presentation
7 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Adocia SA
Access all reports
Adocia SA is a biotechnology company focused on the development of innovative therapies for the treatment of diabetes and other metabolic diseases. The company specializes in creating advanced formulations of already approved therapeutic proteins, aiming to improve their efficacy and patient experience. Adocia's technology platforms are designed to optimize the delivery and performance of these treatments, particularly in the field of insulin therapy. The company is headquartered in Lyon, France, and its shares are listed on the Euronext Paris exchange.
Key slides for Adocia SA
Investor Presentation
Adocia SA
Investor Presentation
Adocia SA
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ADOC
Country
🇫🇷 France